Biblio
“Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.”, JAMA Neurol, vol. 71, no. 11, pp. 1394-404, 2014.
, “A comprehensive genetic association study of Alzheimer disease in African Americans.”, Arch Neurol, vol. 68, no. 12, pp. 1569-79, 2011.
, “Covariate analysis of late-onset Alzheimer disease refines the chromosome 12 locus.”, Mol Psychiatry, vol. 11, no. 3, pp. 280-5, 2006.
, “Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease.”, Neurogenetics, vol. 9, no. 1, pp. 51-60, 2008.
, “Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.”, Hum Mol Genet, vol. 12, no. 24, pp. 3259-67, 2003.
, “Alzheimer's disease: analyzing the missing heritability.”, PLoS One, vol. 8, no. 11, p. e79771, 2013.
, “Genetic control of human brain transcript expression in Alzheimer disease.”, Am J Hum Genet, vol. 84, no. 4, pp. 445-58, 2009.
, “Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.”, Nat Genet, vol. 41, no. 2, pp. 192-8, 2009.
, “Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.”, Nature, vol. 505, no. 7484, pp. 550-554, 2014.
, “Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.”, Neurobiol Aging, vol. 27, no. 8, pp. 1087-93, 2006.
, “The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer's disease.”, Curr Neurol Neurosci Rep, vol. 8, no. 5, pp. 384-91, 2008.
, “Further examination of the candidate genes in chromosome 12p13 locus for late-onset Alzheimer disease.”, Neurogenetics, vol. 9, no. 2, pp. 127-38, 2008.
, “Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.”, PLoS One, vol. 11, no. 2, p. e0148717, 2016.
, “Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.”, Acta Neuropathol, vol. 133, no. 5, pp. 839-856, 2017.
, “Association of apolipoprotein E genotype and Alzheimer disease in African Americans.”, Arch Neurol, vol. 63, no. 3, pp. 431-4, 2006.
, “Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.”, PLoS Med, vol. 15, no. 1, p. e1002487, 2018.
, “Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.”, Am J Epidemiol, vol. 146, no. 5, pp. 373-84, 1997.
, “ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.”, PLoS One, vol. 12, no. 7, p. e0177814, 2017.
, “Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.”, Neurogenetics, vol. 5, no. 4, pp. 201-8, 2004.
, “Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up.”, Alzheimers Dement, vol. 13, no. 12, pp. 1410-1413, 2017.
, “Cohort Profile: the Health and Retirement Study (HRS).”, Int J Epidemiol, vol. 43, no. 2, pp. 576-85, 2014.
, “Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.”, Mol Psychiatry, vol. 9, no. 11, pp. 1042-51, 2004.
, “Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22.”, Am J Hum Genet, vol. 73, no. 5, pp. 1041-51, 2003.
, “Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.”, JAMA, vol. 309, no. 14, pp. 1483-92, 2013.
, “A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.”, JAMA Neurol, vol. 72, no. 4, pp. 414-22, 2015.
,